Other factors that drive the market are the genetic diseases like obesity that is prevailing in all the age groups
due to the changing unhealthy lifestyle and the technological advancements of bio-absorbable stents. The main
reason for maximum amount of deaths caused by the heart diseases across the globe is the CAD (Coronary
artery disease). Nevertheless, the number of Coronary Artery Disease patients has decreased due to the
increasing number of PCIs (percutaneous coronary interventions). This procedure makes use of wide range of
coronary stents which again drives the industry growth. Besides, the expansion of BVS (bio resorb able vascular
scaffold) and the emergence of the coronary stent market offer considerable growth opportunities. Moreover,
the alternative treatment methodologies of CAD, numerous cases of product failure and strict regulations for
product approval will restrict the market growth in the forthcoming years.
The coronary stent industry is categorized on the grounds of product type, delivery modes, material, end-user
and geographic region. On the grounds of product type, the market is divided into drug-eluting stents, bare-
metal stents and bio absorbable stents. In the forecast period, the drug-eluting stents section is predicted to
capture maximum share of the market. This is because the drug-eluting stents possess more benefits than the
bare-metal stents and bio absorbable stents.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/coronary-stent-market-size
The benefits can be stated as reduced risk of restenosis and other major disorders. On the grounds of delivery
modes, the coronary stent market is divided into self-expanding stents and balloon-expanding stents. The
balloon expandable stents is predicted to capture larger market share due to the factors like increasing
regulatory approvals for balloon-expandable stents, greater use of these stents and growing research activities
to enhance technology.
Geographically, the Coronary Stents Market is divided into Europe, North America and Asia, and the rest of the
world. North America is estimated to capture comparatively larger market share followed by Europe. Asia is
projected to capture the coronary stents industry with a good pace in the coming years. Other factors for the
growth of the market in Asia include growing population base, prevalence of heart disease, focus of major
players, increasing adoption of modern technologies and lower manufacturing costs in the area. The prominent
and emerging market players of coronary stent market are Abbott Laboratories, Boston Scientific Corporation,
Biosensors International Group, Ltd., B. Braun Melsungen AG, Terumo Corporation, Medtronic, plc, BIOTRONIK
SE & Co. KG, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Translumina GmbH, and
Vascular Concepts.
Market Segment: